Lupin receives tentative FDA approval for generic Darunavir combination tablets
It will be manufactured at Lupin’s Nagpur facility in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin’s Somerset facility clears U.S. FDA Pre-Approval Inspection for Edaravone Oral Suspension
Lupin announces completion of U.S. FDA Pre-Approval Inspection at its Somerset, New Jersey facility with zero 483 observations
Lupin and Avas launch NaMuscla in Italy
Avas will initially commercialise NaMuscla as a Class C (Tier 2), while Lupin negotiates with AIFA (Agenzia Italiana del Farmaco)…
Lupin gains USFDA approval for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension
The fixed-dose combination is indicated for the treatment of HIV-1 infection in pediatric patients aged at least 3 months and…
Lupin launches Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate…
Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets (RLD Balcoltra) had an estimated annual sale of…
Trends 2025: Redefining the pharma supply chain
Saurabh Gupta, Global Head of Supply Chain, Lupin highlights trends such as AI integration, digitalisation and sustainability that…
Lupin secures tentative U.S. FDA approval for Ivacaftor Oral Granules
Approval paves way for Lupin’s entry into Cystic Fibrosis treatment market
Lupin acquires Huminsulin from Eli Lilly
Lupin has been marketing the Huminsulin range of products through existing distribution and promotion agreements with Lilly, India…
Lupin secures FDA approval for generic Emtricitabine and Tenofovir Alafenamide tablets
Lupin to launch generic version of Descovy with 180-day exclusivity, targeting HIV treatment market
Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio
Lupin expands its diabetes portfolio with the acquisition of GIBTULIO, GIBTULIO MET, and AJADUO trademarks